newsfilter
← Latest News
Business Wire·

Forma Therapeutics to Present at the Jefferies Healthcare Conference

Forma Therapeutics Holdings, Inc. (NASDAQ:FMTX), a clinical-stage biopharmaceutical company focused on sickle cell disease, prostate cancer and other rare hematologic diseases and cancers, today announced that it will participate in the Jefferies Health